Benzinga | Nov 3, 2021 09:16AM EDT

Horizon Therapeutics Q3 EPS $1.75 Beats $1.54 Estimate, Sales $1.04B Beat $979.41M Estimate

Horizon Therapeutics (NASDAQ:HZNP) reported quarterly earnings of $1.75 per share which beat the analyst consensus estimate of $1.54 by 13.64 percent. This is a 0.57 percent increase over earnings of $1.74 per share from the same period last year. The company reported quarterly sales of $1.04 billion which beat the analyst consensus estimate of $979.41 million by 5.88 percent. This is a 62.94 percent increase over sales of $636.43 million the same period last year.